Only about 50% to 60% of U.S. hypertension patients have well-controlled blood pressure, but these leading health systems have achieved 90% control rates.

When doctors came across a patient who barely feels any pain, they found a previously unknown mutation in her genes that suppresses the sensation—a discovery that could open up new possibilities for pain management, according to a report published this week.

American Health Line rounds up the latest health care news in the states.

The Ethisphere Institute has released its 13th annual list of the "World's Most Ethical Companies," which includes several health care companies.

United Parcel Service (UPS) this year will test a service that will dispatch nurses to patients' homes to provide vaccinations, which observers say suggests UPS is looking to be a bigger player in the $85 billion outsourced health care logistics market.

The Department of Justice in a legal filing Monday said a federal appeals court should strike down the entire Affordable Care Act as unconstitutional, changing its previous position that the court should only strike down parts of the law.

Biogen and Japan-based Eisai last week announced a highly anticipated experimental drug designed to treat Alzheimer's disease failed to show clinical benefits, marking the latest failure in Alzheimer's treatment research that has many in the scientific community considering alternative approaches to attack the disease.

For decades, aggressive treatment—namely surgery—has been the go-to treatment for cancer patients, but today, breast surgeons are charting new territory and investigating alternative ways to treat breast cancer.

HHS has received about 18,000 comments on its proposal to overhaul the U.S. drug rebate system—and many of the largest industry stakeholders have yet to weigh in.